Single-Use Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

The Single-Use Bioprocessing Market is experiencing accelerated growth as biopharmaceutical manufacturers increasingly prioritize flexible, scalable, and cost-efficient production systems. In 2025, the market reached a valuation of USD 30.12 billion and is expected to grow substantially to USD 122.92 billion by 2035, reflecting a CAGR of 15.1% during the 2026-2035 period. This expansion underscores the growing reliance on disposable technologies across biologics manufacturing workflows.

A key driver of this shift is the lower capital requirement associated with single-use systems compared to traditional stainless-steel facilities. Disposable platforms eliminate the need for extensive fixed infrastructure and reduce cleaning, sterilization, and validation burdens. Faster setup times further enhance manufacturing agility, enabling biopharmaceutical companies to shorten development cycles and respond rapidly to changing production requirements.

Noteworthy Market Developments

The single-use bioprocessing market operates within an oligopolistic competitive structure led by Thermo Fisher Scientific, Sartorius, Danaher through its Cytiva division, and Merck KGaA. While product innovation remains a core competitive lever, strategic emphasis has increasingly shifted toward supply chain regionalization to mitigate global logistics risks and reduce lead times.

In December 2025, the Telangana state government inaugurated Telangana 1 Bio, India’s first dedicated single-use bioprocess design and scale-up facility, located within Genome Valley. This development highlights the growing institutional support for single-use manufacturing infrastructure in emerging biopharmaceutical hubs. Complementing this trend, Sartorius Stedim Biotech expanded its cleanroom capacity in June 2025, nearly doubling it to 9,000 square meters to support rising global demand for disposable bioprocessing solutions.

Core Growth Drivers

Rising incidence of chronic diseases and global population aging are accelerating demand for biologic therapies such as monoclonal antibodies, vaccines, and cell-based treatments. These therapies require highly controlled, contamination-resistant manufacturing environments, making single-use bioprocessing systems increasingly attractive. Disposable technologies enable rapid production scaling while reducing cross-contamination risks and minimizing downtime between batches, supporting higher manufacturing throughput.

Emerging Opportunity Trends

Sustainability considerations are reshaping the single-use bioprocessing market through the emergence of the “Green Bio” initiative. Despite historical criticism related to plastic waste generation, manufacturers are increasingly investing in recyclable materials, waste reduction strategies, and lifecycle optimization to align disposable technologies with environmental objectives. This shift reflects broader industry efforts to balance operational efficiency with sustainability commitments.

Barriers to Optimization

Regulatory scrutiny surrounding leachables and extractables represents a significant constraint on market optimization. As single-use systems expand into fill-finish and high-sensitivity applications, regulators such as the U.S. Food and Drug Administration are enforcing stricter testing and validation requirements. Compliance with these standards increases development complexity and cost, particularly for new product introductions and material innovations.

Detailed Market Segmentation

By workflow, upstream bioprocessing dominates the market, driven by widespread adoption of single-use bioreactors for cell culture and fermentation. These systems offer plug-and-play functionality, enhanced process control, and reduced turnaround times. By product, simple and peripheral elements represent the largest revenue share, accounting for approximately 40% of the market, reflecting the critical role of tubing, filters, and connectors in maintaining closed, contamination-resistant manufacturing environments.

Segment Breakdown

By Product

• Simple & Peripheral Elements
• Probes & Sensors
• Apparatus & Plants
• Work Equipment

By Workflow

• Upstream Bioprocessing
• Fermentation
• Downstream Bioprocessing

By End-Use

• Biopharmaceutical Manufacturers
• CMOs & CROs
• In-house Manufacturers
• Academic & Clinical Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Geography Breakdown

North America leads the single-use bioprocessing market, driven by extensive retrofitting of existing biomanufacturing facilities rather than large-scale greenfield construction. This strategy allows manufacturers to modernize operations rapidly while minimizing capital expenditure. The region’s dominance is reinforced by the presence of major biopharmaceutical producers, high healthcare spending, and strong adoption of disposable technologies to improve manufacturing flexibility, reduce contamination risk, and accelerate production cycles.

Leading Market Participants

• ABEC Inc.
• Avantor Inc.
• Cellexus
• Celltainer Biotech BV
• CESCO Bioengineering Co.
• Danaher Corp
• Distek Inc.
• Entegris Inc.
• Eppendorf AG
• GEA Group
• Meissner Filtration Products
• Merck
• OmniBRx Biotechnologies
• Parker Hannifin (Domnick Hunter)
• PBS Biotech Inc.
• Repligen Corporation
• Saint-Gobain Life Sciences
• Sartorius AG
• Solventum
• Thermo Fisher Scientific Inc.
• Other Prominent Players